These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4858205)

  • 21. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cycling pool of cells within human brain tumors: in situ cytokinetics using the monoclonal antibody Ki-67.
    Tsanaclis AM; Robert F; Michaud J; Brem S
    Can J Neurol Sci; 1991 Feb; 18(1):12-7. PubMed ID: 1645210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.
    Woosley RE; Mahaley MS; Mahaley JL; Miller GM; Brooks WH
    J Neurosurg; 1977 Dec; 47(6):871-85. PubMed ID: 200722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro immunoreactivity against ethynitrosourea-induced tumours of the nervous system in the rat.
    Toh BH; Guli PG
    Experientia; 1974 Dec; 30(12):1472-3. PubMed ID: 4280356
    [No Abstract]   [Full Text] [Related]  

  • 25. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-bound antiglial immunity in patients with malignant tumors of the brain.
    Wahlström T; Saksela E; Troupp H
    Cell Immunol; 1973 Feb; 6(2):161-70. PubMed ID: 4348395
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain glycoprotein in tumours of the nervous system.
    Girard N; Tayot J; Delpech B; Delpech A; Clement JC; Creissard P; Laumonier R
    J Neuropathol Exp Neurol; 1980 Jan; 39(1):88-98. PubMed ID: 6244373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
    Lauro GM; Grossi M; Di Lorenzo N
    Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
    Blomgren H; Blom U; Ullén H
    Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpesvirus type 1 serum antibodies and brain tumors in humans.
    Hadfield MG; Murray BK; Thomson TA; Young HF
    Clin Neuropathol; 1984; 3(2):68-71. PubMed ID: 6325061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoimmune response in the serum of patients with cerebral gliomas].
    González C; Fumanal FJ; Roda JE
    Rev Clin Esp; 1984 Apr; 173(1):45-7. PubMed ID: 6739896
    [No Abstract]   [Full Text] [Related]  

  • 32. GLYCOGEN CONTENT OF CNS TUMORS.
    TIRASPOLSKAYA MM; TOROPOVA MN
    Fed Proc Transl Suppl; 1964; 23():343-4. PubMed ID: 14145671
    [No Abstract]   [Full Text] [Related]  

  • 33. Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients.
    Kumar R; Kamdar D; Madden L; Hills C; Crooks D; O'Brien D; Greenman J
    Oncol Rep; 2006 Jun; 15(6):1513-6. PubMed ID: 16685388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling.
    Bhattacharjee M; Bose I; Sarkar P; Banerjee C; Dutta S; Ghosh A; Mukherjee J; Acharya S; Goswami S; Mazumdar A; Chaudhuri S; Chaudhuri S
    Cancer Invest; 2006; 24(5):502-13. PubMed ID: 16939959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of cell-mediated immunity to a human brain tumor: use of an in vitro microcytotoxicity assay.
    Brem SS; De Tribolet N; Dohan FC; Kornblith PL
    Surg Forum; 1972; 23(0):428-30. PubMed ID: 4671145
    [No Abstract]   [Full Text] [Related]  

  • 36. Common antigen in meningioma-derived cell cultures.
    Catalano LW; Harter DH; Hsu KC
    Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoembryonic antigen in patients with intracranial tumors.
    Suzuki Y; Tanaka R
    J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour-associated surface antigen(s) in human astrocytomas.
    Coakham HB; Lakshmi MS
    Oncology; 1975; 31(3-4):234-43. PubMed ID: 1196582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SEMINAR ON TUMOURS OF NEUROGENIC ORIGIN.
    IYER CG; SRIRAMACHARI S
    Indian J Pathol Bacteriol; 1964 Jan; 18():1-45. PubMed ID: 14117950
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitogenic lectin receptors of nervous system tumors. Study of gliomas, neural crest tumors, and meningiomas in vitro using phytohemagglutinin and concanavalin A.
    Liwnicz BH
    J Neuropathol Exp Neurol; 1982 May; 41(3):281-97. PubMed ID: 6281395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.